Galliprant: Product Information (Page 6 of 6)

Principal Display Panel — Galliprant 100 mg 30 Tablets Box Label

GALLIPRANT® (grapiprant tablets)

100 mg Flavored Tablets

Store at or below 86° F (30° C)

Caution: Federal (USA)
law restricts this drug to
use by or on the order ofa licensed veterinarian.

For oral use in dogs only

Case Qty: 48 (1 bottle) cartons

30 flavored tablets per bottle

NADA 141-455

Approved by FDA

Manufactured for:

Elanco US Inc.

Greenfield, IN 46140

1-888-545-5973

YL100844H

Principal Display Panel -- Galliprant 100 mg 30 Tablets Box Label
(click image for full-size original)

Principal Display Panel — Galliprant 100 mg 30 Tablets Carton Label

Galliprant ®

(grapiprant tablets)

100 mg

For oral use
in dogs only

EP4 Prostaglandin

Receptor Antagonist NSAID

Caution: Federal (USA) law
restricts this drug to use by
or on the order of a
licensed veterinarian.

30
FLAVORED
TABLETS

ARATANATHERAPEUTICS®

Elanco

Principal Display Panel -- Galliprant 100 mg 30 Tablets Carton Label
(click image for full-size original)

Principal Display Panel — Galliprant 100 mg 30 Tablets Bottle Label

Galliprant ®

(grapiprant tablets)

100 mg

For oral use
in dogs only

EP4 Prostaglandin

Receptor Antagonist

NSAID

Caution: Federal (USA)
law restricts this
drug to use by or
on the order of a
licensed veterinarian.

30
FLAVOREDTABLETS

Principal Display Panel -- Galliprant 100 mg 30 Tablets Bottle Label
(click image for full-size original)

Principal Display Panel — Galliprant 20 mg 90 Tablets Box Label

GALLIPRANT® (grapiprant tablets)

100 mg Flavored Tablets

Store at or below 86° F (30° C)

Caution: Federal (USA)
law restricts this drug to
use by or on the order ofa licensed veterinarian.

For oral use in dogs only

Case Qty: 48 (1 bottle) cartons

90 flavored tablets per bottle

NADA 141-455

Approved by FDA

Manufactured for:

Elanco US Inc.

Greenfield, IN 46140

1-888-545-5973

YL100844I

Principal Display Panel -- Galliprant 20 mg 90 Tablets Box Label
(click image for full-size original)

Principal Display Panel — Galliprant 100 mg 90 Tablets Carton Label

Galliprant ®

(grapiprant tablets)

100 mg

For oral use
in dogs only

EP4 Prostaglandin

Receptor Antagonist NSAID

Caution: Federal (USA) law
restricts this drug to use by
or on the order of a
licensed veterinarian.

90
FLAVORED
TABLETS

ARATANATHERAPEUTICS®

Elanco

Principal Display Panel -- Galliprant 100 mg 90 Tablets Carton Label
(click image for full-size original)

Principal Display Panel — Galliprant 100 mg 90 Tablets Bottle Label

Galliprant ®

(grapiprant tablets)

100 mg

For oral use
in dogs only

EP4 Prostaglandin

Receptor Antagonist

NSAID

Caution: Federal (USA)
law restricts this
drug to use by or
on the order of a
licensed veterinarian.

90
FLAVOREDTABLETS

Principal Display Panel -- Galliprant 100 mg 90 Tablets Bottle Label
(click image for full-size original)
GALLIPRANT grapiprant tablet
Product Information
Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:58198-5810
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Grapiprant (Grapiprant) Grapiprant 20 mg
Product Characteristics
Color brown (Brown) Score 2 pieces
Shape OVAL (OVAL) Size 12mm
Flavor Imprint Code 20;mg;G;G
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:58198-5810-4 48 CARTON in 1 BOX contains a CARTON (58198-5810-1)
1 NDC:58198-5810-1 1 BOTTLE in 1 CARTON This package is contained within the BOX (58198-5810-4) and contains a BOTTLE
1 7 TABLET in 1 BOTTLE This package is contained within a CARTON (58198-5810-1) and a BOX (58198-5810-4)
2 NDC:58198-5810-5 48 CARTON in 1 BOX contains a CARTON (58198-5810-2)
2 NDC:58198-5810-2 1 BOTTLE in 1 CARTON This package is contained within the BOX (58198-5810-5) and contains a BOTTLE
2 30 TABLET in 1 BOTTLE This package is contained within a CARTON (58198-5810-2) and a BOX (58198-5810-5)
3 NDC:58198-5810-6 48 CARTON in 1 BOX contains a CARTON (58198-5810-3)
3 NDC:58198-5810-3 1 BOTTLE in 1 CARTON This package is contained within the BOX (58198-5810-6) and contains a BOTTLE
3 90 TABLET in 1 BOTTLE This package is contained within a CARTON (58198-5810-3) and a BOX (58198-5810-6)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA141455 01/03/2016
GALLIPRANT grapiprant tablet
Product Information
Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:58198-5811
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Grapiprant (Grapiprant) Grapiprant 60 mg
Product Characteristics
Color brown (Brown) Score 2 pieces
Shape OVAL (OVAL) Size 18mm
Flavor Imprint Code 60;mg;G;G
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:58198-5811-4 48 CARTON in 1 BOX contains a CARTON (58198-5811-1)
1 NDC:58198-5811-1 1 BOTTLE in 1 CARTON This package is contained within the BOX (58198-5811-4) and contains a BOTTLE
1 7 TABLET in 1 BOTTLE This package is contained within a CARTON (58198-5811-1) and a BOX (58198-5811-4)
2 NDC:58198-5811-5 48 CARTON in 1 BOX contains a CARTON (58198-5811-2)
2 NDC:58198-5811-2 1 BOTTLE in 1 CARTON This package is contained within the BOX (58198-5811-5) and contains a BOTTLE
2 30 TABLET in 1 BOTTLE This package is contained within a CARTON (58198-5811-2) and a BOX (58198-5811-5)
3 NDC:58198-5811-6 48 CARTON in 1 BOX contains a CARTON (58198-5811-3)
3 NDC:58198-5811-3 1 BOTTLE in 1 CARTON This package is contained within the BOX (58198-5811-6) and contains a BOTTLE
3 90 TABLET in 1 BOTTLE This package is contained within a CARTON (58198-5811-3) and a BOX (58198-5811-6)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA141455 01/03/2016
GALLIPRANT grapiprant tablet
Product Information
Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:58198-5812
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Grapiprant (Grapiprant) Grapiprant 100 mg
Product Characteristics
Color brown (Brown) Score no score
Shape OVAL (OVAL) Size 23mm
Flavor Imprint Code 100;mg;G;G
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:58198-5812-4 48 CARTON in 1 BOX contains a CARTON (58198-5812-1)
1 NDC:58198-5812-1 1 BOTTLE in 1 CARTON This package is contained within the BOX (58198-5812-4) and contains a BOTTLE
1 7 TABLET in 1 BOTTLE This package is contained within a CARTON (58198-5812-1) and a BOX (58198-5812-4)
2 NDC:58198-5812-5 48 CARTON in 1 BOX contains a CARTON (58198-5812-2)
2 NDC:58198-5812-2 1 BOTTLE in 1 CARTON This package is contained within the BOX (58198-5812-5) and contains a BOTTLE
2 30 TABLET in 1 BOTTLE This package is contained within a CARTON (58198-5812-2) and a BOX (58198-5812-5)
3 NDC:58198-5812-6 48 CARTON in 1 BOX contains a CARTON (58198-5812-3)
3 NDC:58198-5812-3 1 BOTTLE in 1 CARTON This package is contained within the BOX (58198-5812-6) and contains a BOTTLE
3 90 TABLET in 1 BOTTLE This package is contained within a CARTON (58198-5812-3) and a BOX (58198-5812-6)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NADA NADA141455 01/03/2016
Labeler — Elanco US Inc. (966985624)

Revised: 03/2023 Elanco US Inc.

VetLabel.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VetLabel.com. Every individual animal healthcare product label entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

https://vetlabel.com/lib/vet/meds/galliprant/page/6/

Vet Label

Medication Sections

RSS Feeds

About

Our database mirrors the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. VetLabel.com provides the full animal health subset of the FDA's repository. Veterinary information provided here is not intended as a substitute for direct consultation with a qualified veterinary professional.

Terms of Use | Copyright © 2023. All Rights Reserved.